DTx beyond Startups, Pharma Takes It All
summary
Panelists examine how digital therapeutics (DTx) are moving beyond startups into broader adoption by pharmaceutical companies and healthcare systems. They discuss implications for regulation, market access, and innovation management, naming roles from consulting, digital health leadership, legal counsel, and a DTx company CEO as contributors to the discussion.
AI-written summary · about
